Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Dev Cell
2009 Jun 01;166:856-66. doi: 10.1016/j.devcel.2009.04.005.
Show Gene links
Show Anatomy links
Metabolic control of oocyte apoptosis mediated by 14-3-3zeta-regulated dephosphorylation of caspase-2.
Nutt LK, Buchakjian MR, Gan E, Darbandi R, Yoon SY, Wu JQ, Miyamoto YJ, Gibbons JA, Gibbon JA, Andersen JL, Freel CD, Tang W, He C, Kurokawa M, Wang Y, Margolis SS, Fissore RA, Kornbluth S.
???displayArticle.abstract???
Xenopus oocyte death is partly controlled by the apoptotic initiator caspase-2 (C2). We reported previously that oocyte nutrient depletion activates C2 upstream of mitochondrial cytochrome c release. Conversely, nutrient-replete oocytes inhibit C2 via S135 phosphorylation catalyzed by calcium/calmodulin-dependent protein kinase II. We now show that C2 phosphorylated at S135 binds 14-3-3zeta, thus preventing C2 dephosphorylation. Moreover, we determined that S135 dephosphorylation is catalyzed by protein phosphatase-1 (PP1), which directly binds C2. Although C2 dephosphorylation is responsive to metabolism, neither PP1 activity nor binding is metabolically regulated. Rather, release of 14-3-3zeta from C2 is controlled by metabolism and allows for C2 dephosphorylation. Accordingly, a C2 mutant unable to bind 14-3-3zeta is highly susceptible to dephosphorylation. Although this mechanism was initially established in Xenopus, we now demonstrate similar control of murine C2 by phosphorylation and 14-3-3 binding in mouse eggs. These findings provide an unexpected evolutionary link between 14-3-3 and metabolism in oocyte death.
Baliga,
The biochemical mechanism of caspase-2 activation.
2004, Pubmed
Baliga,
The biochemical mechanism of caspase-2 activation.
2004,
Pubmed Bergeron,
Defects in regulation of apoptosis in caspase-2-deficient mice.
1998,
Pubmed Cohen,
Protein phosphatase 1--targeted in many directions.
2002,
Pubmed Danial,
Cell death: critical control points.
2004,
Pubmed Danial,
BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis.
2003,
Pubmed Datta,
14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation.
2000,
Pubmed de Schepper,
Age-related changes of glucose-6-phosphate dehydrogenase activity in mouse oocytes.
1987,
Pubmed Duan,
RAIDD is a new 'death' adaptor molecule.
1997,
Pubmed Egloff,
Structural basis for the recognition of regulatory subunits by the catalytic subunit of protein phosphatase 1.
1997,
Pubmed Fissore,
Mechanisms underlying oocyte activation and postovulatory ageing.
2002,
Pubmed Gasco,
Coincident inactivation of 14-3-3sigma and p16INK4a is an early event in vulval squamous neoplasia.
2002,
Pubmed Hanoux,
Caspase-2 involvement during ionizing radiation-induced oocyte death in the mouse ovary.
2007,
Pubmed Kurokawa,
Proteolytic processing of phospholipase Czeta and [Ca2+]i oscillations during mammalian fertilization.
2007,
Pubmed Majewski,
Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak.
2004,
Pubmed Margolis,
PP1 control of M phase entry exerted through 14-3-3-regulated Cdc25 dephosphorylation.
2003,
Pubmed
,
Xenbase Margolis,
A role for PP1 in the Cdc2/Cyclin B-mediated positive feedback activation of Cdc25.
2006,
Pubmed
,
Xenbase Nomura,
14-3-3 Interacts directly with and negatively regulates pro-apoptotic Bax.
2003,
Pubmed Nutt,
Metabolic regulation of oocyte cell death through the CaMKII-mediated phosphorylation of caspase-2.
2005,
Pubmed
,
Xenbase Panaretakis,
Doxorubicin requires the sequential activation of caspase-2, protein kinase Cdelta, and c-Jun NH2-terminal kinase to induce apoptosis.
2005,
Pubmed Pastorino,
Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis.
2002,
Pubmed Rathmell,
Akt-directed glucose metabolism can prevent Bax conformation change and promote growth factor-independent survival.
2003,
Pubmed Read,
A novel Apaf-1-independent putative caspase-2 activation complex.
2002,
Pubmed Rittinger,
Structural analysis of 14-3-3 phosphopeptide complexes identifies a dual role for the nuclear export signal of 14-3-3 in ligand binding.
1999,
Pubmed Robertson,
Caspase-2 acts upstream of mitochondria to promote cytochrome c release during etoposide-induced apoptosis.
2002,
Pubmed Shenolikar,
Protein serine/threonine phosphatases--new avenues for cell regulation.
1994,
Pubmed Smythe,
Systems for the study of nuclear assembly, DNA replication, and nuclear breakdown in Xenopus laevis egg extracts.
1991,
Pubmed
,
Xenbase Sunayama,
JNK antagonizes Akt-mediated survival signals by phosphorylating 14-3-3.
2005,
Pubmed Tinel,
The PIDDosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress.
2004,
Pubmed Tsuruta,
JNK promotes Bax translocation to mitochondria through phosphorylation of 14-3-3 proteins.
2004,
Pubmed Vietri,
Direct interaction between the catalytic subunit of Protein Phosphatase 1 and pRb.
2006,
Pubmed Wakula,
Degeneracy and function of the ubiquitous RVXF motif that mediates binding to protein phosphatase-1.
2003,
Pubmed Yaffe,
The structural basis for 14-3-3:phosphopeptide binding specificity.
1997,
Pubmed Yang,
Structural basis for protein-protein interactions in the 14-3-3 protein family.
2006,
Pubmed Zha,
Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L).
1996,
Pubmed Zhang,
Raf-1 kinase and exoenzyme S interact with 14-3-3zeta through a common site involving lysine 49.
1997,
Pubmed Zhao,
Glycogen synthase kinase 3alpha and 3beta mediate a glucose-sensitive antiapoptotic signaling pathway to stabilize Mcl-1.
2007,
Pubmed
